Park National Corp OH Trims Stock Holdings in Cencora, Inc. $COR

Park National Corp OH decreased its holdings in shares of Cencora, Inc. (NYSE:COR) by 18.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 29,862 shares of the company’s stock after selling 6,748 shares during the quarter. Park National Corp OH’s holdings in Cencora were worth $10,086,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. IAG Wealth Partners LLC purchased a new position in shares of Cencora in the third quarter valued at $30,000. Vermillion & White Wealth Management Group LLC lifted its holdings in Cencora by 69.4% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 105 shares of the company’s stock worth $31,000 after purchasing an additional 43 shares in the last quarter. Cloud Capital Management LLC purchased a new stake in Cencora during the 3rd quarter worth about $31,000. Caitlin John LLC bought a new position in Cencora in the 3rd quarter worth about $31,000. Finally, Westside Investment Management Inc. grew its holdings in Cencora by 200.0% during the 3rd quarter. Westside Investment Management Inc. now owns 105 shares of the company’s stock valued at $33,000 after buying an additional 70 shares in the last quarter. Hedge funds and other institutional investors own 97.52% of the company’s stock.

Insider Transactions at Cencora

In related news, CEO Robert P. Mauch sold 5,096 shares of the company’s stock in a transaction on Tuesday, January 20th. The shares were sold at an average price of $354.73, for a total value of $1,807,704.08. Following the completion of the transaction, the chief executive officer directly owned 66,726 shares in the company, valued at approximately $23,669,713.98. The trade was a 7.10% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.38% of the company’s stock.

Cencora Stock Up 2.1%

COR stock opened at $332.06 on Friday. The company has a current ratio of 0.92, a quick ratio of 0.51 and a debt-to-equity ratio of 3.62. The company’s 50 day moving average is $355.08 and its 200 day moving average is $339.36. The stock has a market cap of $64.59 billion, a price-to-earnings ratio of 39.91, a price-to-earnings-growth ratio of 1.51 and a beta of 0.68. Cencora, Inc. has a 1-year low of $264.33 and a 1-year high of $377.54.

Cencora (NYSE:COR) last announced its earnings results on Wednesday, February 4th. The company reported $4.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.04 by $0.04. Cencora had a net margin of 0.50% and a return on equity of 176.54%. The business had revenue of $85.93 billion during the quarter, compared to analyst estimates of $86.12 billion. During the same period in the previous year, the business posted $3.73 earnings per share. Cencora’s revenue for the quarter was up 5.5% on a year-over-year basis. Sell-side analysts predict that Cencora, Inc. will post 15.37 EPS for the current fiscal year.

Cencora Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 2nd. Stockholders of record on Friday, February 13th were issued a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend was Friday, February 13th. Cencora’s payout ratio is currently 28.85%.

Analyst Ratings Changes

COR has been the topic of several analyst reports. JPMorgan Chase & Co. upped their price target on Cencora from $417.00 to $419.00 and gave the company an “overweight” rating in a research report on Tuesday, February 10th. Wells Fargo & Company raised their price objective on shares of Cencora from $405.00 to $429.00 and gave the company an “overweight” rating in a research report on Tuesday, February 10th. Evercore reaffirmed an “outperform” rating on shares of Cencora in a report on Tuesday. Jefferies Financial Group upgraded shares of Cencora from an “underperform” rating to a “buy” rating in a research note on Thursday, January 22nd. Finally, Robert W. Baird set a $415.00 price target on shares of Cencora in a report on Tuesday, January 13th. Twelve analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat, Cencora currently has an average rating of “Moderate Buy” and a consensus price target of $403.17.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.